Perigon Wealth Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
8,898
+407
| +5% | +$55.9K | 0.03% | 423 |
|
|
2025
Q1 | $1.53M | Buy |
8,491
+202
| +2% | +$36.4K | 0.04% | 362 |
|
|
2024
Q4 | $1.2M | Buy |
8,289
+123
| +2% | +$17.8K | 0.03% | 401 |
|
|
2024
Q3 | $1.49M | Buy |
8,166
+13
| +0.2% | +$2.37K | 0.04% | 331 |
|
|
2024
Q2 | $1.5M | Buy |
8,153
+1,700
| +26% | +$312K | 0.04% | 292 |
|
|
2024
Q1 | $1.15M | Buy |
6,453
+1,579
| +32% | +$281K | 0.03% | 344 |
|
|
2023
Q4 | $605K | Buy |
4,874
+791
| +19% | +$98.1K | 0.02% | 451 |
|
|
2023
Q3 | $474K | Buy |
4,083
+2,324
| +132% | +$270K | 0.02% | 456 |
|
|
2023
Q2 | $207K | Buy |
+1,759
| New | +$207K | 0.01% | 726 |
|